Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy
10018 Ophthalmology Clinic
0301 basic medicine
Inner blood-retina barrier (iBRB)
Fundus Oculi
Photoperiod
610
610 Medicine & health
Mice, Transgenic
2700 General Medicine
Diet, High-Fat
Capillary Permeability
Mice
03 medical and health sciences
Vision loss
Circadian Clocks
Geographic Atrophy
Blood-Retinal Barrier
Chlorocebus aethiops
Animals
Humans
Claudin-5
Fluorescein Angiography
RNA, Small Interfering
ARNTL Transcription Factors
Magnetic Resonance Imaging
Healthy Volunteers
Disease Models, Animal
Age-related macular degeneration (AMD)
Gene Knockdown Techniques
DOI:
10.1172/jci.insight.130273
Publication Date:
2019-08-07T15:00:57Z
AUTHORS (20)
ABSTRACT
Age-related macular degeneration (AMD) is the leading cause of central retinal vision loss worldwide, with an estimated 1 in 10 people over the age of 55 showing early signs of the condition. There are currently no forms of therapy available for the end stage of dry AMD, geographic atrophy (GA). Here, we show that the inner blood-retina barrier (iBRB) is highly dynamic and may play a contributory role in GA development. We have discovered that the gene CLDN5, which encodes claudin-5, a tight junction protein abundantly expressed at the iBRB, is regulated by BMAL1 and the circadian clock. Persistent suppression of claudin-5 expression in mice exposed to a cholesterol-enriched diet induced striking retinal pigment epithelium (RPE) cell atrophy, and persistent targeted suppression of claudin-5 in the macular region of nonhuman primates induced RPE cell atrophy. Moreover, fundus fluorescein angiography in human and nonhuman primate subjects showed increased retinal vascular permeability in the evening compared with the morning. These findings implicate an inner retina-derived component in the early pathophysiological changes observed in AMD, and we suggest that restoring the integrity of the iBRB may represent a novel therapeutic target for the prevention and treatment of GA secondary to dry AMD.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (48)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....